Biopharma Co. Investors Allege Voting Rule Fouls In Del. Suit
BioDelivery Sciences International Inc. stockholders have sued the specialty pharmaceutical company and its board in Delaware's Chancery Court, accusing its directors of enacting charter amendments without proper approval that ended staggered director...To view the full article, register now.
Already a subscriber? Click here to view full article